Example: Heart Attack

Clinical Trials on Neuroectodermal Tumors

Total 5788 results

NCT04563949

Recruiting

DermTech's Non-Invasive Pigmented Lesion Assay to Detect and Track Lesions for Suspected Melanoma and to Determine Outcomes for up to 2 Years

Conditions: Melanoma Detection
NCT04564521

Not yet recruiting

Nitroglycerin for Intra-arterial Chemotherapy in Pediatric Retinoblastoma.

Conditions: Retinoblastoma
NCT04565769

Not yet recruiting

Cognitive Function in Patients Treated for Metastatic Melanoma With Immune Checkpoint Inhibitors

Conditions: Metastatic Melanoma; Cognitive Impairment; Fatigue; Sleep; Depression, Anxiety; Quality of Life; Inflammation; Sickness Behavior; Cancer-related Cognitive Impairment
NCT04562077

Not yet recruiting

Role of Surgery in Treatment of Recurrent Brian Glioma:Prognostic Factors and Outcome

Conditions: Recurrent Glioma; Glioma, Malignant
NCT04562129

Recruiting

IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients

Conditions: Melanoma Stage III; Melanoma Stage IV; Inoperable Disease
NCT04559685

Not yet recruiting

Study of Sonodynamic Therapy in Participants With Recurrent High-Grade Glioma

Conditions: High Grade Glioma
NCT04560166

Not yet recruiting

IT With or Without Naxitamab and GM CSF in Patients With High-Risk Neuroblastoma

Conditions: Neuroblastoma Recurrent
NCT04557956

Not yet recruiting

Testing the Addition of the Anti-cancer Drug, Tazemetostat, to the Usual Treatment (Dabrafenib and Trametinib) for Metastatic Melanoma That Has Progressed on the Usual Treatment

Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8; Metastatic Malignant Neoplasm in the Central Nervous System; Metastatic Melanoma; Pathologic Stage IV Cutaneous Melanoma AJCC v8
NCT04559217

Not yet recruiting

68Ga-DOTATATE Neuroblastoma Imaging Pilot

Conditions: Neuroblastoma
NCT04559230

Not yet recruiting

Phase II, Multicenter, Sacituzumab Govitecan in Recurrent Glioblastoma

Conditions: Glioblastoma
NCT04556929

Not yet recruiting

Enhanced Detection in Glioma Excision

Conditions: Glioma
NCT04557072

Recruiting

Selective Versus Nonselective Alpha-blockade Prior to Pheochromocytoma Resection - Systematic Review and Meta-analysis

Conditions: Pheochromocytoma
NCT04557137

Recruiting

Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia

Conditions: Neuroendocrine Tumors (NET) Health Related Qualito of Life (HRQoL)
NCT04555577

Not yet recruiting

Nedisertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma

Conditions: Glioblastoma; Gliosarcoma
NCT04552223

Not yet recruiting

Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma

Conditions: Metastatic Uveal Melanoma
NCT04552756

Not yet recruiting

Seizures During Radiotherapy for High-grade Gliomas

Conditions: High-grade Glioma
NCT04552847

Recruiting

Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors

Conditions: Neuroendocrine Tumors
NCT04552886

Not yet recruiting

Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma: Phase I Clinical Trial

Conditions: Glioblastoma
NCT04552977

Not yet recruiting

A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma

Conditions: Glioblastoma
NCT04553757

Recruiting

Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma

Conditions: Brain Neoplasm; Low Grade Glioma; Seizure Disorder
NCT04551352

Not yet recruiting

A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

Conditions: Cutaneous Melanoma; Uveal Melanoma; Mucosal Melanoma
NCT04550000

Recruiting

Sample Collection Study in Patients With Suspected Melanoma Utilizing DermTech's Non-invasive Adhesive Patch Biopsy Kits

Conditions: Melanoma (Skin); Pigmented Skin; Nevus
NCT04550247

Recruiting

A Prospective Non-Interventional Study in Participants Receiving Nivolumab in Adjuvant Setting for Resected Melanoma in Real-World Conditions in France

Conditions: Melanoma
NCT04547621

Active, not recruiting

HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM

Conditions: Glioma, Malignant
NCT04547777

Not yet recruiting

Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma

Conditions: Glioma, Malignant
NCT04547855

Recruiting

Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen

Conditions: Glioblastoma
NCT04547946

Not yet recruiting

Observational Study for Melanoma Adjuvant Treatment With Tafinlar® + Mekinist® (Dabrafenib + Trametinib)

Conditions: Malignant Melanoma
NCT04546074

Recruiting

Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma

Conditions: Melanoma
NCT04543188

Not yet recruiting

A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement

Conditions: Malignant Melanoma; Carcinoma, Non-Small-Cell Lung; Brain Neoplasms, Primary; Brain Neoplasms; Malignant Neoplasms
NCT04543201

Not yet recruiting

Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma

Conditions: Glioma
NCT04543955

Not yet recruiting

Telotristat With Lutathera in Neuroendocrine Tumors

Conditions: Neuroendocrine Tumors
NCT04544007

Not yet recruiting

A Phase II Trial of Poly-ICLC for Low-Grade Gliomas

Conditions: NF1; Low-grade Glioma
NCT04544098

Recruiting

Lutathera in People With Pancreatic Neuroendocrine Tumors That Have Spread to the Liver

Conditions: Pancreatic Neuroendocrine Tumors; Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
NCT04544202

Available

Compassionate Use Program BRAF Mutation-positive Patients in the Adjuvant Treatment of Melanoma After Surgical Resection

Conditions: Melanoma; Adjuvant
NCT04544748

Recruiting

A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

Conditions: Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RCC), Malignant Melanoma (MEL)
NCT04545177

Not yet recruiting

Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue

Conditions: Glioblastoma
NCT04541225

Not yet recruiting

Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas

Conditions: Glioma; Glioma, Malignant; Glioma, Mixed; Glial Cell Tumors
NCT04539366

Not yet recruiting

Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, The GD2-CAR PERSIST Trial

Conditions: Recurrent Neuroblastoma; Recurrent Osteosarcoma; Refractory Neuroblastoma; Refractory Osteosarcoma
NCT04539431

Not yet recruiting

Glioma Brain Tumours - E12513 - SensiScreen Glioma

Conditions: Glioma
NCT04540107

Recruiting

Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma

Conditions: Recurrent World Health Organization (WHO) Grade II Glioma; Recurrent WHO Grade III Glioma; WHO Grade II Glioma; WHO Grade III Glioma
NCT04538378

Not yet recruiting

Olaparib (LYNPARZA) Plus Durvalumab (IMFINZI) in EGFR-Mutated Adenocarcinomas That Transform to Small Cell Lung Cancer (SCLC) and Other Neuroendocrine Tumors

Conditions: EGFR-Mutated Non-Small-Cell Lung Carcinoma; Small Cell/Neuroendocrine
NCT04537715

Recruiting

A Two-part Study to Characterize Drug-Drug Interaction Effects on Steady-State Pharmacokinetics of Oral Tazemetostat

Conditions: All Malignancies; Advanced Malignancies; Hematologic Malignancy; Solid Tumor; Follicular Lymphoma (FL); Non-Hodgkin Lymphoma (NHL); Diffuse Large B-Cell Lymphoma (DLBCL); Epithelioid Sarcoma (ES); Synovial Sarcoma; Renal Medullary Carcinoma; Mesothelioma; Rhabdoid Tumor
NCT04536649

Not yet recruiting

Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.

Conditions: Glioblastoma
NCT04532229

Not yet recruiting

Nimotuzumab in Combined With Concurrent Radiochemotherapy in the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Children

Conditions: Diffuse Intrinsic Pontine Glioma
NCT04530006

Not yet recruiting

Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma

Conditions: Glioblastoma Multiforme
NCT04530487

Recruiting

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

Conditions: Desmoplastic Small Round Cell Tumor; Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Recurrent Desmoplastic Small Round Cell Tumor; Recurrent Malignant Peripheral Nerve Sheath Tumor; Recurrent Malignant Solid Neoplasm; Recurrent Neuroblastoma; Recurrent Rhabdomyosarcoma; Refractory Desmoplastic Small Round Cell Tumor; Refractory Malignant Peripheral Nerve Sheath Tumor; Refractory Malignant Solid Neoplasm; Refractory Neuroblastoma; Refractory Rhabdomyosarcoma
NCT04528316

Recruiting

Physical Activity on Postural Stability and Coordination in Children With Posterior Fossa Tumor

Conditions: Posterior Fossa Tumor; Medulloblastoma, Childhood
NCT04528680

Not yet recruiting

Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel for Recurrent Glioblastoma

Conditions: Glioblastoma; Gliosarcoma; GBM; Glioblastoma Multiforme; Glioblastoma, IDH-wildtype; Recurrent Glioblastoma
NCT04526730

Recruiting

Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients

Conditions: Melanoma
NCT04526899

Not yet recruiting

Trial With BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Anti-PD1-refractory/Relapsed, Unresectable Stage III or IV Melanoma

Conditions: Melanoma Stage III; Melanoma Stage IV; Unresectable Melanoma

COOKIE SETTINGS

Clinical Trials on Neuroectodermal Tumors